Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 1790-1798, October 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lenaz, L.
Right arrow Articles by Philips, F. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lenaz, L.
Right arrow Articles by Philips, F. S.

Cytotoxic Effects of 1-β-D-Arabinofuranosyl-5-fluorocytosine and of 1-β-D-Arabinofuranosylcytosine in Proliferating Tissues in Mice1

Luigi Lenaz2, Stephen S. Sternberg and Frederick S. Philips

Division of Pharmacology, Sloan-Kettering Institute for Cancer Research, New York, New York 10021

1-β-D-Arabinofuranosyl-5-fluorocytosine (ara-FC), at doses lower than those generally used for the treatment of mouse leukemias, induces an immediate and complete inhibition of thymidine-2-14C or 32P incorporation into DNA in mouse small intestine, spleen, and thymus, while not affecting 32P incorporation into RNA. The inhibition is reversible and its duration is proportional to the dose given. Whereas karyorrhectic cells appear in the intestinal crypts and in lymph nodes, the spleen and thymus show no histologic effects. However, loss of prelabeled DNA from both spleen and thymus after administration of ara-FC indicates that cell destruction occurs in these organs. The extent of the pathologic process is related to the duration of DNA synthesis inhibition: doses of ara-FC that inhibit thymidine incorporation into DNA by more than 90% for at least 2 hours induce a maximal lesion while a shorter inhibition induces only minimal lesions. The cytotoxic effects are restricted to the proliferating zone of the crypt and to cells comparable in number to that of cells in S-phase. Similar results were obtained in mice given 1-β-D-arabinosylcytosine (ara-C). It is proposed that the lethal effects of ara-FC and ara-C are restricted to cells that are synthesizing DNA, that cells in other phases of the mitotic cycle escape damage, and that inhibition of DNA synthesis must be sustained for several hours in order to induce irreversible damage in sensitive S-phase cells.

1 Aided by Grant CA 08748 from the National Cancer Institute, USPHS.

2 Visiting Research Fellow from the Institute of Histology and General Physiology, University of Bologna, Italy.

Received 1/ 2/69. Accepted 6/11/69.




This article has been cited by other articles:


Home page
ScienceHome page
G. Lux, L. Marton, and S. Baylin
Ornithine decarboxylase is important in intestinal mucosal maturation and recovery from injury in rats
Science, October 10, 1980; 210(4466): 195 - 198.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.